A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China
NCT: NCT07821957 · RECRUITING
Brief Summary
Intracranial aneurysm, as a common cerebrovascular disease, has a variety of treatment methods, including surgical treatment and endovascular treatment. Among these treatment methods, flow diverters have attracted much attention due to their unique therapeutic principles. Flow diverters help promote thrombus formation within the aneurysm by altering the direction and dynamics of blood flow, thereby achieving the purpose of treatment. 1-5 Flow diverters such as the Pipeline™ device have been proven to be safe and effective for the treatment of intracranial aneurysms and have gradually been recognized as the preferred device for the management of intracranial aneurysms.
Frequently Asked Questions
What is A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China?
A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China is a clinical trial registered under NCT07821957. Current status: RECRUITING.
What is the status of NCT07821957?
The current status of NCT07821957 (A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China) is: RECRUITING.
When did A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China start?
A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China started on 2026-01-06.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.